# US 2017/0254775 A1 · Isotopically-Labeled Proteome Standards

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0254775 A1
- Document ID: US20170254775A1
- Status: Published application
- Kind: A1
- Application number: 15/597,928
- Filed: 2017-05-17
- Published: 2017-09-07
- Earliest claimed: 2005-03-07
- Assignees: Life Technologies Corporation
- Applicants: Life Technologies Corporation
- Inventors: John LEITE; Robert POPE; Mahbod HAJIVANDI; Xiquan LIANG
- Web page: https://patentgrep.com/patent/US20170254775A1

## CPC

- G01N 27/623: combined with mass spectrometry
- G01N 33/60: involving radioactive labelled substances
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 33/6851: {Methods of protein analysis involving laser desorption ionisation mass spectrometry}
- G01N 2458/15: Non-radioactive isotope labels, e.g. for detection by mass spectrometry
- Y10T 436/24: Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

The invention provides methods for quantifying biomolecules, such as polypeptides in mass spectrometric analysis. The methods include use of a biomolecule standard having at least one atomic isotope different than that of the naturally occurring isotopes in the biomolecule of interest. Methods of the present invention also include methods for quantifying biomolecules where the copy biomolecule standard is made by expressing the biomolecule using a recombinant cell. Further included are the biomolecule standards themselves, method for making such standards, kits, systems, reagents, and engineered cells relating to the use of biomolecule standards in mass spectrometric analysis.

## Claims

### Claim 1

A method for quantifying one or more polypeptides comprising:
providing a sample having a polypeptide of interest to be quantified;
providing a copy of the polypeptide of interest, the copy made using at least one isotope having a mass different than that of naturally-occurring isotopes of the polypeptide of interest;
quantifying the copy polypeptide of interest;
introducing a known quantity of the copy into the sample;
analyzing the sample by mass spectrometry; and
comparing obtained mass spectrometry peak pairs resulting from the one or more polypeptides or one or more fragments thereof of the sample, and the copy or one or more fragments thereof, to determine the quantity of the one or more polypeptides in the sample;
is wherein the mass spectrometry peak pairs differ in mass by an amount corresponding to the isotope with the different mass taking into account the number of isotope atoms in each ion monitored.

### Claim 2 (depends on 1)

The method of claim 1, wherein the quantity being determined is a relative quantity.

### Claim 3 (depends on 1)

The method of claim 1, wherein the quantity being determined is an absolute quantity.

### Claim 4 (depends on 1)

The method of claim 1, wherein the copy of the polypeptide of interest is made by synthesis in cultured cells.

### Claim 5 (depends on 4)

The method of claim 4, wherein said cultured cells are prokaryotic cells or eukaryotic cells.

### Claim 6 (depends on 5)

The method of claim 5, wherein said cells are prokaryotic cells.

### Claim 7 (depends on 6)

The method of claim 6, wherein said prokaryotic cells are selected from the group consisting of E. coli cells, Pseudomonas cells, Rhodobacter cells, Bacillus cells, Streptomyces cells, Erwinia cells, Klebsiella cells, Serratia cells and Salmonella cells.

### Claim 8 (depends on 7)

The method of claim 7, wherein said cells are E. coli cells.

### Claim 9 (depends on 5)

The method of claim 5, wherein said cells are eukaryotic cells.

### Claim 10 (depends on 9)

The method of claim 9, wherein said cells are selected from the group consisting of yeast cells, mammalian cells, marsupial cells, avian cells, insect cells, fish cells, amphibian cells, reptile cells, and nematode cells.

### Claim 11 (depends on 10)

The method of claim 10, wherein said cells are yeast cells.

### Claim 12 (depends on 10)

The method of claim 10, wherein said cells are mammalian cells.

### Claim 13 (depends on 10)

The method of claim 10, wherein said cells are insect cells.

### Claim 14 (depends on 10)

The method of claim 10, wherein said cells are avian cells.

### Claim 15 (depends on 4)

The method of claim 4, wherein the copy is made by expressing the polypeptide using an engineered cell.

### Claim 16 (depends on 15)

The method of claim 15, wherein the engineered cell is a cell derived from a cell or cell line other than a cell or cell line from which the sample is obtained.

### Claim 17 (depends on 1)

The method of claim 1, wherein the copy is made using in vitro translation.

### Claim 18 (depends on 17)

The method of claim 17, wherein said in vitro translation system comprises a prokaryotic cell extract.

### Claim 19 (depends on 17)

The method of claim 17, wherein said in vitro translation system comprises a eukaryotic cell extract.

### Claim 20 (depends on 1)

The method of claim 1, wherein said copy is made using at least one amino acid with an isotope pool having a mass distribution different than that of naturally-occurring isotopes in the polypeptide of interest.

### Claim 21 (depends on 20)

The method of claim 20, wherein the isotope pool comprises substantially non-radioactive isotopes.

### Claim 22 (depends on 20)

The method of claim 20, wherein the copy comprises at least one substantially nonradioactive isotope selected from the group consisting of 15N, 13C, 18O, 2H and 34S in an amino acid.

### Claim 23 (depends on 22)

The method of claim 22, wherein said amino acid is selected from the group consisting of Arg, Lys, Asp, Glu, Met, Trp, Ser, Thr, Tyr, and Asn.

### Claim 24 (depends on 1)

The method of claim 1, wherein said quantifying uses a protein quantitation assay.

### Claim 25 (depends on 24)

The method of claim 24, wherein said quantifying uses an assay selected from the group consisting of a Bradford assay, a bicinchoninic acid (BCA) assay, a Lowry assay, an ELISA, and an assay with a fluorescence readout.

### Claim 26 (depends on 25)

The method of claim 25, wherein said quantifying uses an assay with a fluorescence readout.

### Claim 27 (depends on 26)

The method of claim 26, wherein said assay with a fluorescence readout is a FluoroProfile™ assay, an EZQ™ assay, a NanoOrange® assay or a QuantiT™ assay.

### Claim 28 (depends on 1)

The method of claim 1, wherein said sample comprises one or more organisms, one or more embryos, one or more cells, a cell supernatant, a cell extract, a cell lysate, or a cell-free biological mimetic system.

### Claim 29 (depends on 1)

The method of claim 1, wherein said sample comprises bodily fluid or biological tissue.

### Claim 30 (depends on 1)

The method of claim 1, further comprising
forming fragments of the polypeptide by cleavage with an enzyme or proteolytic agent.

### Claim 31 (depends on 30)

The method of claim 30, wherein the enzyme or proteolytic agent comprises at least one of protease, a serine protease, a sulfhydryl protease, a metalloprotease, and cyanogen bromide

### Claim 32 (depends on 1)

The method of claim 1, further comprising
providing at least a second sample comprising said polypeptide of interest or a variant thereof;
introducing a known quantity of said copy into said second sample;
analyzing by mass spectrometry said second sample to determine the quantity of said polypeptide of interest or variant thereof in said second sample; and
comparing the quantity of at least one polypeptide of interest or variant thereof of said sample to the quantity of at least one polypeptide of interest or variant thereof of said second sample.

### Claim 33 (depends on 32)

The method of claim 32, wherein said second sample is from a different source than the source of said sample.

### Claim 34 (depends on 33)

The method of claim 33, wherein said second sample is from a different organism than the source of said sample.

### Claim 35 (depends on 33)

The method of claim 33, wherein said second sample is from cells, bodily fluid, or tissue of a disease state and said sample is from cells, bodily fluid, or tissue of a normal state.

### Claim 36 (depends on 33)

The method of claim 33, wherein said second sample has been exposed to a different set of conditions than said sample.

### Claim 37 (depends on 36)

The method of claim 36, wherein the different set of conditions is one or more of: species or strain from which the sample is obtained; chemical exposure; genetic manipulation; feeding regimen; environmental difference; aging or developmental stage; or difference in exposure to one or more hormones, growth factors, or cytokines.

### Claim 38 (depends on 37)

The method of claim 37, wherein the genetic manipulation comprises performing genetic engineering.

### Claim 39 (depends on 38)

The method of claim 38, wherein said genetic engineering comprises one or more of homologous recombination, expression or introduction of antisense RNA, expression or introduction of RNAi, inappropriate expression of a gene, or expression of a dominant negative form of a gene.

### Claim 40 (depends on 37)

The method of claim 37, wherein the chemical exposure comprises at least one of exposure to a drug or metabolite thereof, exposure to a drug candidate or metabolite thereof, addition of a known or suspected inhibitor or a metabolite thereof, or addition of a known or suspected toxin or metabolite thereof.

### Claim 41 (depends on 37)

The method of claim 37, wherein the environmental difference comprises the presence of at least one of a virus, a bacteria, and a carcinogen.

### Claim 42

A method for quantifying one or more biomolecules comprising:
providing at least one sample having a biomolecule of interest to be quantified;
providing a copy of the biomolecule of interest, the copy made or replicated using recombinant expression and said copy having at least one isotope having a mass different than that of naturally occurring isotopes of the biomolecule of interest;
quantifying the copy biomolecule of interest;
introducing a known quantity of the copy into the sample;
analyzing the sample by mass spectrometry; and
comparing obtained mass spectrometry peak pairs resulting from the one or more biomolecules or one or more fragments thereof, and the copy or one or more fragments thereof, to determine the quantity of the one or more biomolecules in said at least one sample.

### Claim 43 (depends on 42)

The method of claim 42, wherein said one or more biomolecules is selected from the group consisting of a peptide, a protein, a nucleic acid molecule, a lipid, and a polysaccharide.

### Claim 44

A kit for quantifying a biomolecule by mass spectrometry comprising
a means for synthesizing a biomolecule standard using recombinant expression,
wherein said biomolecule standard includes at least one atomic isotope that under mass spectrometry produces at least one peak distinguishing said biomolecule standard from otherwise identical biomolecules lacking said at least one atomic isotope.

### Claim 45

A kit comprising at least one amino acid containing one or more atomic isotopes that are different in molecular mass from naturally-occurring isotopes; and one or more of:
a culture medium for in vitro culture;
is a template instruction for synthesizing a biomolecule standard;
a cell lysis reagent;
a resin for purifying said biomolecule standard;
a protein quantitation reagent;
an enzyme or chemical reagent capable of cleaving said biomolecule standard;
a host cell;
a vector; and
a polymerase.

### Claim 46 (depends on 45)

The kit of claim 45, wherein said isotope is an atom selected from the group consisting of 15N, 13C, 18O, 2H and 34S.

### Claim 47 (depends on 45)

The kit of claim 45, wherein said amino acid is selected from the group consisting of Arg, Lys, Asp, Glu, Met, Trp, Set, Thr, Tyr, and Asn.

### Claim 48 (depends on 45)

The kit of claim 45, wherein said enzyme is selected from the group consisting of trypsin, Endo-Lys-C, Endo-Glu-C, AspN protease, a yeast peptidase, V-8 protease, pepsin, subtilisin, proteinase 1c, and tobacco etch virus protease, and TRYPle.™

### Claim 49 (depends on 45)

The kit of claim 45, wherein said chemical preparation comprises Cyanogen Bromide.

### Claim 50 (depends on 45)

The kit of claim 45, wherein said vector encodes a tag sequence.

### Claim 51 (depends on 45)

The kit of claim 45, wherein said vector comprises sequence that binds a chemical ligand or group selected from the group consisting of polyHistidine, FLAG, c-myc, hemagglutinin, GST, biotin, GFP, polycysteine, and tetracysteine.

### Claim 52

A kit comprising at least one amino acid containing one or more atomic isotopes that are different in molecular mass from naturally-occurring isotopes; and one or more of:
a protein synthesis system;
a template instruction for synthesizing a biomolecule standard;
a resin for purifying said biomolecule standard;
a protein quantitation reagent;
an enzyme or chemical reagent capable of cleaving said biomolecule standard;
a resin for purifying said biomolecule standard;
an enzyme or chemical preparation capable of cleaving said biomolecule standard;
a vector; and
a polymerase.

### Claim 53 (depends on 52)

The kit of claim 52, wherein said synthesis system comprises an extract selected from the group consisting of a bacterial extract, a eukaryotic extract, a plant extract, a mammalian extract, and an insect extract.

### Claim 54 (depends on 52)

The kit of claim 52, further comprising at least one buffer for in vitro protein synthesis.

### Claim 55 (depends on 52)

The kit of claim 52, wherein said isotope is an atom selected from the group consisting of 15N, 13C, 18O, 2H and 34S.

### Claim 56 (depends on 52)

The kit of claim 52, wherein said amino acid is selected from the group consisting of Arg, Lys, Asp, Glu, Met, Trp, Ser, Thr, Tyr, and Asn.

### Claim 57 (depends on 52)

The kit of claim 52, wherein said enzyme is selected from the group consisting of trypsin, Endo-Lys-C, Endo-Glu-C, AspN protease, a yeast peptidase, V-8 protease, pepsin, subtilisin, proteinase 1c, and tobacco etch virus protease and TRYPle.™

### Claim 58 (depends on 52)

The kit of claim 52, wherein said chemical reagent comprises Cyanogen Bromide.

### Claim 59 (depends on 52)

The kit of claim 52, wherein said vector encodes a tag sequence.

### Claim 60 (depends on 52)

The kit of claim 52, wherein said vector comprises a sequence that binds a chemical ligand or group selected from the group consisting of polyHistidine, FLAG, c-myc, hemagglutinin, GST, biotin, GFP, polycysteine, and tetracysteine.

### Claim 61

A method of making an isotopically-labeled biomolecule standard comprising
expressing a copy of a biomolecule of interest in recombinant cells cultured in media that comprises at least one isotopically-labeled precursor molecule;
purifying said isotopically-labeled biomolecule standard; and
quantitating said isotopically-labeled biomolecule standard;
wherein the copy is enriched with at least one heavy isotope labeled molecule.

### Claim 62 (depends on 61)

The method of claim 61, further comprising forming fragments of said biomolecule precursor using at least one enzyme or at least one chemical reagent.

### Claim 63 (depends on 61)

The method of claim 61, wherein said biomolecule standard is a protein or peptide standard.

### Claim 64 (depends on 61)

An isotopically-labeled biomolecule standard produced by the method of claim 61.

### Claim 65 (depends on 62)

An isotopically-labeled biomolecule standard produced by the method of claim 62.

### Claim 66 (depends on 63)

An isotopically-labeled biomolecule standard produced by the method of claim 63.

### Claim 67

A method of making an isotopically-labeled polypeptide standard comprising
expressing a copy of a biomolecule of interest in a protein synthesis system that comprises at least one isotopically-labeled precursor molecule;
purifying said isotopically-labeled biomolecule standard; and
quantitating said isotopically-labeled biomolecule standard;
wherein the copy is an isotopically-labeled polypeptide standard.

### Claim 68 (depends on 67)

The method of claim 67, further comprising forming fragments of said isotopically-labeled polypeptide standard using at least one enzyme or at least one chemical reagent.

### Claim 69 (depends on 67)

An isotopically-labeled polypeptide standard produced by the method of claim 67.

### Claim 70 (depends on 68)

An isotopically-labeled polypeptide standard produced by the method of claim 68.
